Advent Acquires Majority Stake in New Zealand Clinical Research Group
US-based Advent, a leading global private equity investor, has signed a definitive agreement to acquire a majority shareholding in New Zealand Clinical Research Group (NZCR Group), a leading clinical trials and medical research organisation in New Zealand and Australia. NZCR Group’s clinician shareholders and management, along with local private equity investor Waterman Capital, are retaining […]
Advent Acquires Majority Stake in New Zealand Clinical Research Group Read More »
